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Ethanol stimulating transient receptor potential vanilloid 1 (TRPV1) on primary
sensory neurons promotes neurogenic inflammation, including calcitonin gene-
related peptide (CGRP)-mediated coronary dilation. Alcoholic beverages trigger
migraine attacks and activation of trigeminal neurons plays a role in migraine.
We have investigated in guinea pigs whether ethanol by TRPV1 stimulation
causes neurogenic inflammation in the trigeminovascular system. Ethanol-
evoked release of neuropeptides from slices of dura mater was abolished by Ca2+
removal, capsaicin pretreatment and the TRPV1 antagonist, capsazepine. Intra-
gastric ethanol increased plasma extravasation in dura mater, an effect abolished
by capsazepine and the NK1 receptor antagonist, SR140333, and caused vasodi-
lation around the middle meningeal artery, an effect abolished by capsazepine
and the CGRP receptor antagonist, BIBN4096BS. Vasodilation of meningeal
vessels by TRPV1 activation and CGRP release may be relevant to the mecha-
nism by which alcohol ingestion triggers migraine attacks. BIBN4096BS, CGRP,
dural neurogenic vasodilation, ethanol, TRPV1
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Introduction
It is well accepted that migraine attacks may initiate
spontaneously or may be triggered by specific
factors, which, acting alone or in combination,
enhance the probability of the attack (1). Observa-
tional studies have identified a variety of potential
triggers, including fatigue (2), stress, mental tension
(3, 4), weather changes (5, 6), menstruation (4, 6)
and certain foods (6). Among nutritional factors,
alcoholic beverages are well-known inducers of
headache in healthy subjects (7). Migraineurs seem
to be particularly sensitive to all alcoholic drinks,
including red wine and beer (4, 8). The observed
negative association between migraine and chronic
alcohol consumption indirectly confirms the
migraine-precipitating properties of alcohol (9). At
present, the mechanism of alcohol-evoked headache
is poorly understood. For example, sulphites or
other non-alcoholic ingredients have been proposed
to contribute to the migraine-precipitating effect of
wine (10, 11). However, the possibility that ethanol
(EtOH) per se triggers the migraine attack by a
vasodilating effect has long been cited (12).
A subpopulation of primary nociceptive
neurons, uniquely sensitive to capsaicin, the hot
principle present in the genus Capsicum, contains
and releases the neuropeptides calcitonin gene-
related peptide (CGRP) and the tachykinins,P.N. and M.T. contributed equally to this work.
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substance P (SP) and neurokinin A (13, 14). CGRP
and tachykinins, released from peripheral endings
of primary sensory neurons, cause a series of
biological responses collectively referred to as
neurogenic inflammation (15). The CGRP-
mediated arterial vasodilation, and tachykinin-
mediated plasma protein extravasation, represent
the main aspects of neurogenic inflammation (15).
The release of sensory neuropeptide from termi-
nals of trigeminal neurons distributed around
meningeal blood vessels and their biological
effects on these vessels have been proposed as the
underlying mechanism of the migraine attack (16,
17). However, tachykinin NK1 receptor antago-
nists, despite their ability to block neurogenic
plasma leakage, have failed to ameliorate
migraine attacks in various clinical studies (18,
19). Increased CGRP levels in the blood of cranial
origin during spontaneous or provoked migraine
attacks (20, 21) have suggested a possible role of
CGRP in migraine pathogenesis. The observation
that CGRP administration causes migraine head-
ache (22) and, more importantly, the clinical
finding that BIBN4096BS, a high-affinity and selec-
tive CGRP receptor antagonist (23), reduces the
pain and other symptoms associated with
migraine attacks (24), indicate a primary role for
neurogenic vasodilation and CGRP in migraine.
Sensitivity of nociceptive primary sensory
neurons to capsaicin is given by the expression of
the transient receptor potential vanilloid 1
(TRPV1) channel (25), which is also activated by
noxious temperature (43–52°C), extracellular aci-
dosis (pH 6–5) (26, 27), and diverse lipid deriva-
tives (28–30). We have recently reported that
EtOH stimulates TRPV1 channels and releases
SP/CGRP from central and peripheral terminals
of primary sensory neurons, by lowering the
threshold temperature for channel activation (31).
More recently, it has been shown that EtOH by a
TRPV1-mediated neurogenic mechanism produces
a CGRP-dependent vasodilation in porcine coro-
nary and human gastric arteries (32). Finally,
expression of TRPV1 mRNA and protein in
human trigeminal ganglion neurons (33) supports
the hypothesis that TRPV1-dependent release of
CGRP contributes to the pain originating from the
trigeminovascular system in man. The aim of the
present study was to explore whether EtOH, by
TRPV1 stimulation, activates trigeminal primary
sensory neurons and by this mechanism releases
sensory neuropeptides and causes neurogenic
inflammatory responses, including arterial vasodi-
lation in the guinea pig dura mater.
Methods
Animals and reagents
Male albino Dunkin Hartley guinea pigs (250–350 g;
Charles River, Lecco, Italy) were acclimatized in
cages (24 0.5°C) for 1 week after delivery and
were allowed free access to water and standard
rodent diet. All experiments complied with
European Community guidelines for animal care
(86/609/EC). Formal approval to conduct the
experiments described was obtained from the
animal subjects review board of the University of
Florence.
CGRP- and SP-like immunoreactivity release
Guinea pigs were terminally anaesthetized and
decapitated. A trigeminal rhizotomy was performed
via a ventromedian skull base craniotomy and the
dura mater was carefully detached from the skull-
cap, at 4°C. Thick slices (~0.3 mm) were placed in
2-ml chambers and superfused at 0.4 ml/min with
a Krebs’ solution of the following composition (in
mM): NaCl 119, NaHCO3 25, KH2PO4 1.2, MgSO4
1.5, CaCl2 2.5, KCl 4.7 and D-glucose 11. The fol-
lowing agents were added to the Krebs’ solution:
0.1% bovine serum albumin (BSA), 1 mM phos-
phoramidon and 1 mM captopril (to minimize
peptide degradation), maintained at 37°C and
gassed with 95% O2 and 5% CO2. After a 90-min
stabilization period, two prestimuli samples were
taken at 10-min intervals followed by a third set of
samples during stimulation. A final poststimulus
10-min sample was also collected. At the end of the
experiment, tissues were blotted and weighed. Frac-
tions were freeze dried, reconstituted with assay
buffer and analysed by enzyme immunoassays for
CGRP- and SP-like immunoreactivity (LI) according
to the methods reported previously (31, 34). The
detection limits of the assays were 5 pg/ml for
CGRP and 2 pg/ml for SP. Stimulated CGRP-LI and
SP-LI release was calculated by subtracting the
mean prestimulus value from those values obtained
during and after stimulation. EtOH 3% and the
highest concentration of capsaicin (1 mM) and cap-
sazepine (10 mM) showed no significant cross-
reactivity with CGRP and SP antisera.
Plasma extravasation
Overnight fasted guinea pigs were anaesthetized
intraperitoneally with sodium pentobarbital
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(60 mg/kg) and a plastic cannula was inserted into
the trachea following tracheotomy to facilitate res-
piration. Guinea pigs were then artificially venti-
lated (60 breaths/min) through a rodent ventilator
(7025; Ugo Basile, Comerio, Italy). Evans Blue dye
(30 mg/kg) was injected into the jugular vein 1 min
prior to the intraperitoneal (i.p.; 1 ml/kg) or intra-
gastric (i.g.; 1 ml/kg) administration of EtOH or
1 min prior to the intravenous (i.v.) administration
of SP (1 nmol/kg). After 30 additional minutes, the
chest was opened and an incision made in the left
ventricle. A cannula was then inserted through the
left ventricle into the ascending aorta and approxi-
mately 200 ml of sterile saline (0.9%) was perfused
at a pressure of 100 mmHg. The dura mater was
then carefully removed, weighed and incubated
in 1 ml of formamide for 24 h in the dark, at
room temperature. The amount of extravasated
Evans Blue was measured spectrophotometrically
at 620 nm. Systemic pretreatments with capsaze-
pine (4 mg/kg, i.p), SR140333 (1 mg/kg, i.v.),
BIBN4960BS (1 mg/kg, i.v.) or their respective
vehicles were given 10 min prior to injection of the
dye.
Dural blood flow
Guinea pigs were fasted overnight and anaesthe-
tized with an initial dose of urethane (1500 mg/kg,
i.p.), followed by additional doses of 15 mg/kg, i.p.,
when required, to maintain the appropriate level of
anaesthesia. Body temperature of the animals was
kept at 37°C with a heating pad. The head of the
animals was fixed in a stereotaxic frame. The scalp
was incised along the midline and the parietal skin
pulled aside. Using a manual drill (Harvard Instru-
ment, Holliston, MA, USA), a cranial window of
4 ¥ 6 mm was made into the parietal bone to expose
the dura mater for the measurement of dural blood
flow. At a distance of 1 mm from the meningeal
layers, the probe (needle type, tip diameter 0.8 mm)
of a Laser Doppler Flow Meter (Perimed Instru-
ments, Milan, Italy) was fixed pointing near a
branch of the middle meningeal artery. To minimize
flow signals from the cortical blood vessels, record-
ing sites were selected along the larger branches of
the medial meningeal artery lying distant from the
visible cortical blood vessels. Under these condi-
tions, the registered laser Doppler signal derived
nearly exclusively from the meningeal blood flow.
The cranial window was carefully filled with a
modified synthetic interstitial fluid (SIF) containing
(mM): NaCl 135, KCl 5, MgCl2 1, CaCl2 5, glucose
10 and HEPES 10 (35). Capsazepine, SR140333,
BIBN4960BS (1 mg/kg, i.v.) or their respective
vehicles were given 10 min prior to administration
of the stimuli. After a 45-min stabilization period,
either acetylcholine (1 mM, 100 ml by local adminis-
tration) or EtOH (1 ml/kg, i.g.) was given. At the
end of the experiment animals were killed with an
overdose of urethane (2800 mg/kg, i.p.). Baseline
flow was calculated by the mean flow value mea-
sured during a 5-min period prior to stimulus. The
percentage change in blood flow was calculated as
reported previously (35).
Drugs
Drugs and reagents were obtained from the indi-
cated companies: capsaicin, capsazepine, substance
P, urethane and pentobarbital and Evans Blue dye
(Sigma, Milan, Italy), SR140333 and BIBN4960BS
were kind gifts of Dr X. Emonds-Alt (Sanofi Recher-
ché, Montpellier, France), and Dr H. Doods
(Boeringher-Mannheim, Mannheim, Germany),
respectively.
Statistical analysis
All values are mean  standard error of the mean
(SEM). Differences between the groups were analy-
sed by analysis of variance (ANOVA), followed
by the post hoc Dunnett’s test for multiple
comparisons.
Results
CGRP and SP release
EtOH (3%) produced an increase in CGRP-LI and
SP-LI outflow from slices of guinea pig trigeminal
ganglia (195 53 fmol/g per 20 min and 33
8 fmol/g per 20 min, respectively, n = 6 each),
which was reduced in both cases by >80% in experi-
ments performed in a Ca2+-free medium, plus 1 mM
ethylenediamine tetraacetic acid. Similarly, capsai-
cin pretreatment (10 mM, for 20 min, 60 min before
EtOH administration), a procedure known to
desensitize sensory nerve terminals, reduced by
>80% both CGRP-LI and SP-LI outflow evoked by
EtOH. In another sets of experiments, in the pres-
ence of the TRPV1 antagonist, capsazepine (10 mM),
CGRP and SP release evoked by EtOH was reduced
by >70% (Fig. 1a,b). Exposure to EtOH (3%)
increased CGRP-LI and SP-LI outflow (45
9 fmol/g per 20 min and 11 2 fmol/g per 20 min,
respectively, n = 8) from slices of guinea pig dura
mater. In experiments performed with a Ca2+-free
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medium, the increase in CGRP-LI and SP-LI
outflow evoked by EtOH was reduced by about
80%. Desensitization to capsaicin diminished EtOH-
induced increase in the outflow of CGRP-LI and
SP-LI by >90%. Pretreatment with capsazepine
(10 mM) significantly reduced EtOH-evoked release
of CGRP-LI and SP-LI by >70% (Fig. 1c,d). Pretreat-
ment with capsaicin (10 mM for 20 min) or the pres-
ence of capsazepine (10 mM) did not affect baseline
CGRP-LI or SP-LI outflow (not shown). SP-LI and
CGRP-LI release from slices of trigeminal ganglia or
dura mater evoked by high KCl (80 mM) was unaf-
fected by capsazepine (not shown).
Plasma extravasation
The baseline level of the extravasated Evans Blue
dye in the guinea pig dura mater after the i.p.
administration of EtOH vehicle (0.9% saline) was
15 2 ng/g of tissue (n = 12). In a first set
of experiments, i.p. administration of 1 ml/kg of
EtOH increased significantly the amount of
S
P
-L
I
(f
m
ol
/g
/2
0m
in
)
*
*
0
20
10
d
0
100
50
*
*
C
G
R
P
-L
I
(f
m
ol
/g
/2
0 
m
in
)
c
Ethanol 3% Ethanol 3%
* *
0
100
200
300
*
*
C
G
R
P
-L
I
(f
m
ol
/g
/2
0 
m
in
)
0
25
50
*
*
S
P
-L
I
(f
m
ol
/g
/2
0m
in
)
a b
Ethanol 3% Ethanol 3%
*
*
CPZCaps
Des
Veh –Ca2+ CPZCaps
Des
Veh –Ca2+
CPZCaps
Des
Veh –Ca2+ CPZCaps
Des
Veh –Ca2+
Figure 1 Outflow of calcitonin gene-related peptide (CGRP)- and substance P (SP)-like immunoreactivity (LI) induced by
ethanol from slices of guinea pig trigeminal ganglia (a,b) or dura mater (c,d) is reduced in a Ca2+-free medium, plus 1 mM
ethylenediamine tetraaceticacid (– Ca2+), after capsaicin desensitization (10 mM for 20 min, Caps Des) or in the presence of
capsazepine (10 mM, CPZ). Each entry is the mean  SEM of at least six experiments. Veh, Capsazepine vehicle. *P < 0.05
vs. Veh.
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extravasated Evans Blue dye in the dura mater
(34 2, n = 6, P < 0.05) (Fig. 2). Evans Blue dye
extravasation induced by i.p. EtOH was practically
abolished after pretreatment with SR140333 (1 mg/
kg, i.v.) or capsazepine (4 mg/kg, i.p.) (Fig. 2a). In
the second set of experiments EtOH (1 ml/kg) was
administered intragastrically through a cannula
that reached the gastric cavity. By this route of
administration, Evans Blue dye extravasation
evoked by EtOH vehicle (1 ml, 0.9% saline) was
17  5 ng/g of tissue (n = 6). I.g. administration of
EtOH increased significantly the Evans Blue dye
extravasation (32 2 ng/g of tissue, n = 6, P < 0.05).
Extravasation induced by i.g. EtOH was abated
after pretreatment with SR140333 (1 mg/kg, i.v.) or
capsazepine (4 mg/kg, i.p.) (Fig. 2b). Pretreatment
with SR140333 (1 mg/kg, i.v.), but not with cap-
sazepine (4 mg/kg, i.p.) abolished Evans Blue dye
extravasation evoked by SP (10 nmol/kg i.v.), indi-
cating selectivity of capsazepine in EtOH-evoked
extravasation (Fig. 2b). BIBN4960BS (1 mg/kg, i.v.)
did not affect baseline Evans Blue extravasation
(not shown). The increase in Evans Blue extravasa-
tion induced by i.g. EtOH (1 ml/kg) was not altered
in animals pretreated with BIBN4960BS (1 mg/kg,
i.v., 26.7 2.1 ng/mg of tissue, n = 6) when com-
pared with that observed in vehicle-treated animals
(29.4 3.2 ng/mg of tissue, n = 7).
Dural blood flow
In preliminary experiments, basal blood flow in the
dura mater of the guinea pig (259.0 34.5 perfu-
sion units, n = 5) was not affected by the local
application of SIF (100 ml). In contrast, acetylcholine
(1 mM, 100 ml) application to the exposed dura
mater caused a rapid increase in blood flow
(127 1.8% of baseline, n = 5) that returned to base-
line level after 6.2 1.6 min (n = 6). I.g. administra-
tion of EtOH vehicle (1 ml/kg, 0.9% saline) did not
affect baseline blood flow in the dura mater (not
shown). I.g. administration of EtOH (1 ml/kg) after
pretreatment with the combination of the vehicles
of capsazepine and BIBN4960BS (10% Tween 80 and
10% dimethylsulphoxide in 0.9% saline) produced a
slow increase in dural blood flow that peaked
(234 42% of baseline, n = 8) 48 8 min after drug
administration. The sustained increase in blood
flow evoked by i.g. EtOH declined slowly without
returning to baseline value after 2 h. Pretreat-
ment with capsazepine (4 mg/kg, i.p.) or with
BIBN4960BS (1 mg/kg, i.v.) abated the increase in
dural blood flow evoked by i.g. EtOH (Fig. 3a,b).
In contrast, pretreatment with capsazepine or
BIBN4960BS did not affect the moderate increase in
dural blood flow produced by local application of
acetylcholine (Fig. 3a,b), indicating selectivity of
these pharmacological interventions.
Discussion
This study provides evidence that EtOH causes
neurogenic inflammatory responses, including
plasma extravasation and arterial vasodilation, in
the guinea pig meninges by a TRPV1-mediated
release of sensory neuropeptides. Among many
other neuronal effects, EtOH has been shown to
stimulate nociceptive primary sensory neurons by
lowering the threshold temperature for TRPV1 acti-
vation (31). This effect results in a Ca2+-dependent
release of sensory neuropeptides in the spinal cord
and in peripheral tissues, including the oesophagus
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Figure 2 (a) Plasma protein extravasation in the guinea
pig dura mater induced by intraperitoneal (1 ml/kg, i.p.)
or intragastric (1 ml/kg, i.g.) administration of ethanol was
abated by pretreatment with the tachykinin NK1 receptor
antagonist, SR140333 (1 mg/kg, i.v.) and by the TRPV1
antagonist, capsazepine (4 mg/kg, i.p., CPZ). (b) Effect of
capsazepine on substance P (SP)-induced Evans Blue dye
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six experiments. Sal (0.9% saline), ethanol vehicle; Veh,
combination of capsazepine and SR140333 vehicles.
*P < 0.05 vs. Sal; #P < 0.05 vs. Veh.
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(31) and airways (36). Our present experiments
have shown that a similar phenomenon also occurs
at the trigeminal level. In fact, EtOH increased the
outflow of SP and CGRP from guinea pig trigemi-
nal ganglia and from the dura mater, which is
densely innervated by terminals of trigeminal
neurons. Ca2+ dependency and sensitivity to capsai-
cin desensitization indicated that EtOH promotes
a neurosecretory process from capsaicin-sensitive
sensory cell bodies (trigeminal ganglion) or nerve
terminals (dura mater). Finally, abolition by cap-
sazepine confirmed also at the trigeminal level that
EtOH-evoked release of sensory neuropeptides is
mediated by activation of TRPV1. It is noteworthy
that TRPV1 is coexpressed in human trigeminal
ganglion neurons with the sensory neuropeptides,
SP and CGRP (33). Thus, one may hypothesize that
the mechanism described in the guinea pig may
also occur in man.
EtOH-evoked release of sensory neuropeptides
has been associated with neurogenic inflammatory
responses, namely plasma extravasation in the rat
oesophagus and in the guinea pig airways and
bronchoconstriction in the guinea pig (31, 36). In
this context, it is important to mention that plasma
protein extravasation is a phenomenon exclusively
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mediated by activation of tachykinin NK1 receptors
in postcapillary venules. Accordingly, EtOH-evoked
plasma extravasation in the oesophagus and
airways was abated by an NK1 receptor antagonist
(31, 36). More recently, it has been shown that
exposure to EtOH of pig coronary arteries or
human gastroepiploic arteries is associated with a
Ca2+-dependent and capsaicin-sensitive release of
CGRP and with a CGRP-mediated arterial vasodi-
lation (32). Likewise, plasma leakage, arterial
vasodilation evoked by EtOH was inhibited by
capsazepine. These in vivo findings confirm the
conclusion derived from release experiments
regarding the role of TRPV1 in EtOH-evoked
sensory nerve stimulation. The ability of SR140333
to block plasma protein leakage in the dura mater
shows that this effect is mediated by SP release and
NK1 receptor activation on endothelial cells of post-
capillary venules. There is strong evidence support-
ing the view that capsaicin-induced hyperaemia in
mammals and in man is mediated by CGRP release
from sensory nerve terminals (37). CGRP is one of
the most potent vasodilator substances described to
date (38), and CGRP receptor antagonists have been
reported to inhibit neurogenic arterial vasodilation
in a large series of in vivo preparations (39).
However, it should be noted that the CGRP recep-
tor antagonist, BIBN4096BS, did not affect cerebral
or systemic circulation in humans (40). In addition,
BIBN4096BS selectively prevented the vasodilation
induced by CGRP and by transcranial electrical
stimulation in the rat middle meningeal artery, but
not in cortical pial arteries (41). This unique phar-
macodynamic profile might result from the absence
of a vasodilatory action of CGRP in the resting state
and by the hydrophilic nature of this compound
(23), which is unlikely to pass the blood–brain
barrier (40, 41) Here, we have shown that
BIBN4960BS and capsazepine inhibit EtOH-evoked
increase in blood flow in the middle meningeal
artery. Selectivity of these pharmacological inter-
ventions was supported by the observation that
both capsazepine and BIBN4960BS did not affect
acetylcholine-induced vasodilation. Thus, ingestion
of EtOH causes neurogenic vasodilation in
meningeal arterial vessels through TRPV1 stimula-
tion and the release of CGRP from perivascular
sensory nerve endings.
Neurogenic inflammation in the meninges has
been proposed as the underlying mechanism of
migraine headache (16). Originally, the term neuro-
genic inflammation was mainly, if not exclusively,
referred to neurogenic plasma protein extravasa-
tion. The inhibitory action of antimigraine drugs,
such as ergot derivatives and triptans, on neuro-
genic plasma protein leakage in the meninges
further supported this view (42–44). However, clini-
cal observation that selective and potent NK1 recep-
tor antagonists (18, 19) did not ameliorate the pain
and other symptoms of the migraine attack
excluded a major role for tachykinins and NK1
receptors in migraine. At the same time, the
hypothesis that the release of CGRP, which dilates
cranial blood vessels (45) and stimulates sensory
nerve transmission (46), key role in the mechanism
of migraine has received much attention and
experimental support. In addition to findings
obtained in experimental animals, a recent clinical
study has shown a beneficial effect of the high-
affinity, peptoid antagonist of the CGRP receptor,
BIBN4096BS (23), on the pain and other symptoms
associated with the migraine attack (24).
EtOH may produce both vasoconstriction (47–49)
and vasodilation (50, 51) on arterial vessels, includ-
ing cerebral arteries. The different effect appears to
be related, among several factors, to the size of the
vessel and to species differences. However, the
action of EtOH on sensory nerve terminals exclu-
sively produces a vasodilatory effect, mediated by
TRPV1 activation and CGRP release (32). This neu-
ronal effect of EtOH may be relevant in clinical
medicine, as EtOH-induced neurogenic vasodila-
tion of coronary arteries (32) could contribute to the
so-called French paradox (52). The protective effect
of alcoholic beverages in coronary artery disease
seems, in fact, directly dependent on their alcoholic
content (53). However, alcoholic drinks, although
protecting the heart, may be detrimental in
migraineurs because they can trigger migraine
attacks (8). This effect of alcohol has been linked to
the vasodilatory properties of the substance (12).
However, the precise mechanism through which
EtOH provokes the migraine attack remains
unknown. Here, we found that in guinea pigs,
EtOH, by TRPV1 stimulation, produces, the excita-
tion of primary sensory neurons, the release of
sensory neuropeptides and the production of
neurogenic inflammatory responses. The prolonged
vasodilation, resulting from neural stimulation,
observed following i.g. EtOH administration,
somehow mirrors the delayed onset of the migraine
headache after the ingestion of alcoholic beverages.
Thus, both the excitatory action on nociceptive
trigeminal nerve endings and the ability to cause
CGRP-dependent vasodilation might contribute to
trigger the migraine attack. The quantity of i.g.
EtOH able to produce neuronal activation and
neurogenic vasodilation (1 ml/kg) in guinea pigs
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corresponds to the alcoholic content of three to four
glasses of wine, an amount which, in common
experience, is sufficient to trigger a migraine attack.
We propose that the ability of alcoholic beverages to
trigger migraine attacks in susceptible individuals
is due, at least in part, to the stimulation by EtOH
of TRPV1 on trigeminal neurons and the resulting
CGRP-mediated arterial vasodilation.
Acknowledgements
This study was supported by grants from MUR, Rome and
Ente Cassa di Risparmio di Firenze, Florence, Italy.
References
1 The Headache Classification Committee of the Interna-
tional Headache Society.The International Classification
of Headache Disorders 2nd edition. Cephalalgia 2004;
1:9–160.
2 Wober C, Holzhammer J, Zeitlhofer J, Wessely P, Wober-
Bingol C. Trigger factors of migraine and tension-type
headache: experience and knowledge of the patients.
J Headache Pain 2006; 7:188–95.
3 Spierings EL, Ranke AH, Honkoop PC. Precipitating and
aggravating factors of migraine versus tension-type head-
ache. Headache 2001; 41:554–8.
4 Rasmussen BK. Migraine and tension-type headache in a
general population: precipitating factors, female hor-
mones, sleep pattern and relation to lifestyle. Pain 1993;
53:65–72.
5 Villeneuve PJ, Szyszkowicz M, Stieb D, Bourque DA.
Weather and emergency room visits for migraine head-
aches in Ottawa. Can Headache 2006; 46:64–72.
6 Zivadinov R, Willheim K, Sepic-Grahovac D, Jurjevic A,
Bucuk M, Brnabic-Razmilic O et al. Migraine and tension-
type headache in Croatia: a population-based survey of
precipitating factors. Cephalalgia 2003; 23:336–43.
7 Chabriat H, Danchot J, Michel P, Joire JE, Henry P.
Precipitating factors of headache. A prospective study in
a national control-matched survey in migraineurs and
nonmigraineurs. Headache 1999; 39:335–8.
8 Peatfield RC. Relationships between food, wine, and
beer-precipitated migrainous headaches. Headache 1995;
35:355–7.
9 Aamodt AH, Stovner LJ, Hagen K, Brathen G, Zwart J.
Headache prevalence related to smoking and alcohol
use. The Head-HUNT Study. Eur J Neurol 2006; 13:
1233–8.
10 Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium-
dependent vasorelaxing activity of wine and other grape
products. Am J Physiol 1993; 265:774–8.
11 Flesch M, Schwarz A, Bohm M. Effects of red and white
wine on endothelium-dependent vasorelaxation of rat
aorta and human coronary arteries. Am J Physiol Heart
Circ Physiol 1998; 275:1183–90.
12 Lance J. Mechanism and management of headache. New
York: Butterworths 1969.
13 Holzer P. Capsaicin: cellular targets, mechanisms of
action, and selectivity for thin sensory neurons. Pharma-
col Rev 1991; 43:143–201.
14 Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors
and mechanisms. Pharmacol Rev 1999; 51:159–212.
15 Geppetti P, Holzer P. Neurogenic inflammation. Boca
Raton: CRC Press 1996.
16 Moskowitz MA. The neurobiology of vascular head pain.
Ann Neurol 1984; 16:157–68.
17 Edvinsson L. Blockade of CGRP receptors in the intrac-
ranial vasculature: a new target in the treatment of head-
ache. Cephalalgia 2004; 24:611–22.
18 Goldstein DJ, Wang O, Saper JR, Stoltz R, Silberstein SD,
Mathew NT. Ineffectiveness of neurokinin-1 antagonist in
acute migraine: a crossover study. Cephalalgia 1997;
17:785–90.
19 Diener HC. RPR100893, a substance-P antagonist, is not
effective in the treatment of migraine attacks. Cephalalgia
2003; 23:183–5.
20 Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide
release in the extracerebral circulation of humans during
migraine headache. Ann Neurol 1990; 28:183–7.
21 Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B,
Nemeth J et al. NO-induced migraine attack: strong
increase in plasma calcitonin gene-related peptide
(CGRP) concentration and negative correlation with
platelet serotonin release. Pain 2003; 106:461–70.
22 Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK,
Sperling B, Olesen J. CGRP may play a causative role in
migraine. Cephalalgia 2002; 22:54–61.
23 Doods H, Hallermayer G, Wu D, Entzeroth M, Rudolf K,
Engel W, Eberlein W. Pharmacological profile of
BIBN4096BS, the first selective small molecule CGRP
antagonist. Br J Pharmacol 2000; 129:420–3.
24 Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D,
Meier U et al. Calcitonin gene-related peptide receptor
antagonist BIBN 4096 BS for the acute treatment of
migraine. N Engl J Med 2004; 350:1104–10.
25 Caterina MJ, Schumacher MA, Tominaga M, Rosen TA,
Levine JD, Julius D. The capsaicin receptor: a heat-
activated ion channel in the pain pathway. Nature 1997;
389:816–24.
26 Bevan S, Geppetti P. Protons: small stimulants of
capsaicin-sensitive sensory nerves. Trends Neurosci 1994;
17:509–12.
27 Tominaga M, Caterina MJ, Malmberg AB, Rosen TA,
Gilbert H, Skinner K et al. The cloned capsaicin receptor
integrates multiple pain-producing stimuli. Neuron 1998;
21:531–43.
28 Zygmunt PM, Petersson J, Andersson DA, Chuang H,
Sorgard M, Di Marzo V et al. Vanilloid receptors on
sensory nerves mediate the vasodilator action of ananda-
mide. Nature 1999; 400:452–7.
29 Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J et
al. Direct activation of capsaicin receptors by products of
lipoxygenases: endogenous capsaicin-like substances.
Proc Natl Acad Sci USA 2000; 97:6155–60.
30 van der Stelt M, Trevisani M, Vellani V, De Petrocellis L,
Schiano Moriello A, Campi B et al. Anandamide acts as
an intracellular messenger amplifying Ca2+ influx via
TRPV1 channels. EMBO J 2005; 24:3026–37.
16 P Nicoletti et al.
© Blackwell Publishing Ltd Cephalalgia, 2007, 28, 9–17
31 Trevisani M, Smart D, Gunthorpe MJ, Tognetto M, Bar-
bieri M, Campi B et al. Ethanol elicits and potentiates
nociceptor responses via the vanilloid receptor-1. Nat
Neurosci 2002; 5:546–51.
32 Gazzieri D, Trevisani M, Tarantini F, Bechi P, Masotti G,
Gensini GF et al. Ethanol dilates coronary arteries and
increases coronary flow via transient receptor potential
vanilloid 1 and calcitonin gene-related peptide. Cardio-
vasc Res 2006; 70:589–99.
33 Hou M, Uddman R, Tajti J, Kanje M, Edvinsson L. Cap-
saicin receptor immunoreactivity in the human trigeminal
ganglion. Neurosci Lett 2002; 330:223–6.
34 Frobert Y, Nevers MC, Amadesi S, Volland H, Brune P,
Geppetti P et al. A sensitive sandwich enzyme immu-
noassay for calcitonin gene-related peptide (CGRP): char-
acterization and application. Peptides 1999; 20:275–84.
35 Kurosawa M, Messlinger K, Pawlak M, Schmidt RF.
Increase of meningeal blood flow after electrical stimula-
tion of rat dura mater encephali: mediation by calcitonin
gene-related peptide. Br J Pharmacol 1995; 114:1397–402.
36 Trevisani M, Gazzieri D, Benvenuti F, Campi B, Dinh QT,
Groneberg DA et al. Ethanol causes inflammation in the
airways by a neurogenic and TRPV1-dependent mecha-
nism. J Pharmacol Exp Ther 2004; 309:1167–73.
37 Holzer P. Peptidergic sensory neurons in the control of
vascular functions: mechanisms and significance in the
cutaneous and splanchnic vascular beds. Rev Physiol
Biochem Pharmacol 1992; 121:49–146.
38 Brain SD, Cambridge H. Calcitonin gene-related peptide:
vasoactive effects and potential therapeutic role. General
Pharmacol 1996; 27:607–11.
39 Brain SD, Grant AD. Vascular actions of calcitonin gene-
related peptide and adrenomedullin. Physiol Rev 2004;
84:903–34.
40 Petersen KA, Birk S, Lassen LH, Kruuse C, Jonassen O,
Lesko L, Olesen J. The CGRP-antagonist, BIBN4096BS
does not affect cerebral or systemic haemodynamics in
healthy volunteers. Cephalalgia 2005; 25:139–47.
41 Petersen KA, Birk S, Doods H, Edvinsson L, Olesen J.
Inhibitory effect of BIBN4096BS on cephalic vasodilata-
tion induced by CGRP or transcranial electrical stimula-
tion in the rat. Br J Pharmacol 2004; 143:697–704.
42 Markowitz S, Saito K, Moskowitz MA. Neurogenically
mediated plasma extravasation in dura mater: effect of
ergot alkaloids. A possible mechanism of action in
vascular headache. Cephalalgia 1988; 8:83–91.
43 Markowitz S, Saito K, Moskowitz MA. Neurogenically
mediated leakage of plasma protein occurs from blood
vessels in dura mater but not brain. J Neurosci 1987;
7:4129–36.
44 Williamson DJ, Hill RG, Shepheard SL, Hargreaves RJ.
The anti-migraine 5-HT (1B/1D) agonist rizatriptan
inhibits neurogenic dural vasodilation in anaesthetized
guinea-pigs. Br J Pharmacol 2001; 133:1029–34.
45 Edvinsson L. Calcitonin gene-related peptide (CGRP) and
the pathophysiology of headache: therapeutic implica-
tions. CNS Drugs 2001; 15:745–53.
46 Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-
related peptide (CGRP) modulates nociceptive trigemi-
novascular transmission in the cat. Br J Pharmacol 2004;
142:1171–81.
47 Zhang A, Altura BT, Altura BM. Ethanol-induced con-
traction of cerebral arteries in diverse mammals and its
mechanism of action. Eur J Pharmacol 1993; 248:229–36.
48 Altura BM, Altura BT, Gebrewold A. Alcohol-induced
spasms of cerebral blood vessels: relation to cerebrovas-
cular accidents and sudden death. Science 1983;
220:331–3.
49 Yong T, Gilmore JP, Joyner WL, Mayhan WG. In vivo
responses of allografted cerebral parenchymal arterioles
to ethanol and angiotensin II: effect of calcium channel
blockade. Int J Microcirc Clin Exp 1992; 11:417–24.
50 Mayhan WG, Didion SP. Acute effects of ethanol on
responses of cerebral arterioles. Stroke 1995; 26:2097–102.
51 Altura BM, Ogunkoya A, Gebrewold A, Altura BT.
Effects of ethanol on terminal arterioles and muscular
venules: direct observations on the microcirculation. J
Cardiovasc Pharmacol 1979; 1:97–113.
52 Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the
French paradox for coronary heart disease. Lancet 1992;
339:1523–6.
53 Mukamal KJ, Conigrave KM, Mittleman MA, Camargo
CA Jr, Stampfer MJ, Willett WC, Rimm EB. Roles of
drinking pattern and type of alcohol consumed in coro-
nary heart disease in men. N Engl J Med 2003; 348:109–
18.
Ethanol causes neurogenic vasodilation in the guinea pig 17
© Blackwell Publishing Ltd Cephalalgia, 2007, 28, 9–17
